NEW YORK (GenomeWeb) – The Wellcome Trust Sanger Institute today announced that spin-off firm 14M Genomics will receive £12.5 million ($19.7 million) in equity financing from investment firm Syncona Partners to develop oncology diagnostic and treatment services.

14M Genomics will combine genomic and clinical data sets for major cancers, which will enable clinicians to stratify patients to better inform diagnosis, prognosis, and treatment.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.